Embracing Change
Chris discusses the high costs associated with drug development, emphasizing the need to overcome industry conservatism to bring effective medicines to patients. He draws parallels to Tesla's supercharging network, highlighting the necessity of taking bold steps when faced with resistance to change. As they pivot to producing their own drugs, the conversation touches on the cultural shifts and challenges that accompany this new approach in a rapidly evolving landscape.In this clip
From this podcast
The AI Podcast
Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230
Related Questions